Linking the septin expression with carcinogenesis

Molecular Biology Reports

Volumn 37, Issue 7, 2010, Pages 3601-3608

  Liu, Ming ^a   Shen, Suqin ^a   Chen, Fang ^a   Yu, Wenbo ^a   Yu, Long ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Carcinogenesis; Expression; ONCOMINE; Septin

Indexed keywords

SEPTIN; SEPTIN 10; SEPTIN 11; SEPTIN 2; SEPTIN 4; SEPTIN 8; SEPTIN 9; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MALE; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS; SEPTINS; UP-REGULATION;

EID: 77956948324     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0009-2     Document Type: Article

References (43)

1. CM Field D Kellogg 1999 Septins: cytoskeletal polymers or signalling GTPases? Trends Cell Biol 9 387 394 1:CAS:528:DyaK1MXmsVWht7k%3D 10.1016/S0962-8924(99)01632-3 10481176
2. LH Hartwell 1971 Genetic control of cell division cycle in yeast.4. genes controlling bud emergence and cytokinesis Exp Cell Res 69 265 1:CAS:528:DyaE38Xktlyqtg%3D%3D 10.1016/0014-4827(71)90223-0 4950437
3. M Kinoshita S Kumar A Mizoguchi C Ide A Kinoshita T Haraguchi, et al. 1997 Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures Genes Dev 11 1535 1547 1:CAS:528:DyaK2sXktFWqt7c%3D 10.1101/gad.11.12.1535 9203580
4. CS Weirich JP Erzberger Y Barral 2008 The septin family of GTPases: architecture and dynamics Nat Rev Mol Cell Biol 9 478 489 1:CAS:528: DC%2BD1cXmt1OlsLk%3D 10.1038/nrm2407 18478031
5. SC Hsu CD Hazuka R Roth DL Foletti J Heuser RH Scheller 1998 Subunit composition, protein interactions, and structures of the mammalian brain sec6/8 complex and septin filaments Neuron 20 1111 1122 1:CAS:528:DyaK1cXktFOksrs%3D 10.1016/S0896-6273(00)80493-6 9655500
6. CL Beites H Xie R Bowser WS Trimble 1999 The septin CDCrel-1 binds syntaxin and inhibits exocytosis Nat Neurosci 2 434 439 1:CAS:528: DyaK1MXivVyls7Y%3D 10.1038/8100 10321247
7. S Larisch Y Yi R Lotan H Kerner S Eimerl W Tony Parks, et al. 2000 A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif Nat Cell Biol 2 915 921 1:CAS:528:DC%2BD3cXptFSnurs%3D 10.1038/35046566 11146656
8. SEH Russell PA Hall 2005 Do septins have a role in cancer? Br J Cancer 93 499 503 1:CAS:528:DC%2BD2MXpsFalurY%3D 10.1038/sj.bjc.6602753 16136025
9. PA Hall SE Russell 2004 The pathobiology of the septin gene family J Pathol 204 489 505 1:CAS:528:DC%2BD2cXhtVCgsrjL 10.1002/path.1654 15495264
10. T Taki H Ohnishi K Shinohara M Sako F Bessho M Yanagisawa, et al. 1999 AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25) Cancer Res 59 4261 4265 1:CAS:528: DyaK1MXlvVSmsrY%3D 10485469
11. R Ono T Taki T Taketani H Kawaguchi M Taniwaki T Okamura, et al. 2002 SEPTIN6, a human homologue to mouse SEPTIN6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and xq24 Cancer Res 62 333 337 1:CAS:528:DC%2BD38XhtVyhsLY%3D 11809673
12. M Osaka JD Rowley NJ Zeleznik-Le 1999 MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25) Proc Natl Acad Sci USA 96 6428 6433 1:CAS:528: DyaK1MXksFKktL8%3D 10.1073/pnas.96.11.6428 10339604
13. K Kojima I Sakai A Hasegawa H Niiya T Azuma Y Matsuo, et al. 2004 FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23) Leukemia 18 998 1005 1:CAS:528:DC%2BD2cXjtlyitr0%3D 10.1038/sj.leu.2403334 14999297
14. DS Kim SL Hubbard A Peraud B Salhia K Sakai JT Rutka 2004 Analysis of mammalian septin expression in human malignant brain tumors Neoplasia 6 168 178 1:CAS:528:DC%2BD2cXks1SjsL8%3D 10.1593/neo.03310 15140406
15. M Tanaka H Kijima J Itoh T Matsuda T Tanaka 2002 Impaired expression of a human septin family gene Bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo Cancer Gene Ther 9 483 488 1:CAS:528:DC%2BD38XksVGhsb0%3D 10.1038/sj.cgt.7700460 12032658
16. S Larisch YS Yi R Lotan H Kerner S Eimerl WT Parks, et al. 2000 A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif Nat Cell Biol 2 915 921 1:CAS:528:DC%2BD3cXptFSnurs%3D 10.1038/35046566 11146656
17. Y Gottfried A Rotem R Lotan H Steller S Larisch 2004 The mitochondrial ARTS protein promotes apoptosis through targeting XIAP EMBO J 23 1627 1635 1:CAS:528:DC%2BD2cXivVGgsLk%3D 10.1038/sj.emboj.7600155 15029247
18. R Elhasid D Sahar A Merling Y Zivony A Rotem M Ben-Arush, et al. 2004 Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients Oncogene 23 5468 5475 1:CAS:528: DC%2BD2cXls1CjtrY%3D 10.1038/sj.onc.1207725 15122323
19. SE Russell MA McIlhatton JF Burrows PG Donaghy S Chanduloy EM Petty, et al. 2000 Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors Cancer Res 60 4729 4734 1:CAS:528:DC%2BD3cXmsFWhsr8%3D 10987277
20. LM Kalikin HL Sims EM Petty 2000 Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors Genomics 63 165 172 1:CAS:528:DC%2BD3cXhtVKisrg%3D 10.1006/geno.1999.6077 10673329
21. M Scott PL Hyland G McGregor KJ Hillan SEH Russell PA Hall 2005 Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours Oncogene 24 4688 4700 1:CAS:528:DC%2BD2MXlvVGhsbo%3D 10.1038/sj.onc.1208574 15782116
22. ME Gonzalez EA Peterson LM Privette JL Loffreda-Wren LM Kalikin EM Petty 2007 High SEPT9-v1 expression in human breast cancer cells is associated with oncogenic phenotypes Cancer Res 67 8554 8564 1:CAS:528:DC%2BD2sXhtVCit73J 10.1158/0008-5472.CAN-07-1474 17875694
23. ME Gonzalez O Makarova EA Peterson LM Privette EM Petty 2009 Up-regulation of SEPT9-v1 stabilizes c-Jun-N-Terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells Cell Signal 21 477 487 1:CAS:528:DC%2BD1MXhvF2rtbY%3D 10.1016/j.cellsig.2008.11.007 19071215
24. DR Rhodes S Kalyana-Sundaram V Mahavisno R Varambally JJ Yu BB Briggs, et al. 2007 Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles Neoplasia 9 166 180 1:CAS:528: DC%2BD2sXktVaru74%3D 10.1593/neo.07112 17356713
25. DR Rhodes J Yu K Shanker N Deshpande R Varambally D Ghosh, et al. 2004 ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 1 6 1:CAS:528:DC%2BD2cXjslSgtrY%3D 15068665
26. HS Phillips S Kharbanda R Chen WF Forrest RH Soriano TD Wu, et al. 2006 Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 157 173 1:CAS:528:DC%2BD28XivFWjtL4%3D 10.1016/j.ccr.2006.02.019 16530701
27. R Shai T Shi TJ Kremen S Horvath LM Liau TF Cloughesy, et al. 2003 Gene expression profiling identifies molecular subtypes of gliomas Oncogene 22 4918 4923 1:CAS:528:DC%2BD3sXlvVKnsrY%3D 10.1038/sj.onc.1206753 12894235
28. B Kreike H Halfwerk P Kristel A Glas H Peterse H Bartelink, et al. 2006 Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy Clin Cancer Res 12 5705 5712 1:CAS:528:DC%2BD28XhtVartbrF 10.1158/1078-0432.CCR-06-0805 17020974
29. MJ van de Vijver YD He LJ van't Veer H Dai AAM Hart DW Voskuil, et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009 10.1056/NEJMoa021967 12490681
30. S Tomida K Koshikawa Y Yatabe T Harano N Ogura T Mitsudomi, et al. 2004 Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients Oncogene 23 5360 5370 1:CAS:528:DC%2BD2cXlsVOmsLY%3D 10.1038/sj.onc.1207697 15064725
31. E Wurmbach YB Chen G Khitrov W Zhang S Roayaie M Schwartz, et al. 2007 Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma Hepatology 45 938 947 1:CAS:528:DC%2BD2sXltlWitrw%3D 10.1002/hep.21622 17393520
32. A Cromer A Carles R Millon G Ganguli F Chalmel F Lemaire, et al. 2004 Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis Oncogene 23 2484 2498 1:CAS:528:DC%2BD2cXis1Gmsbo%3D 10.1038/sj.onc.1207345 14676830
33. DR Carrasco G Tonon Y Huang Y Zhang R Sinha B Feng, et al. 2006 High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients Cancer Cell 9 313 325 1:CAS:528: DC%2BD28XjvFeiurg%3D 10.1016/j.ccr.2006.03.019 16616336
34. WA Freije FE Castro-Vargas ZX Fang S Horvath T Cloughesy LM Liau, et al. 2004 Gene expression profiling of gliomas strongly predicts survival Cancer Res 64 6503 6510 1:CAS:528:DC%2BD2cXnsFOltbg%3D 10.1158/0008-5472.CAN-04-0452 15374961
35. SS Dave G Wright B Tan A Rosenwald RD Gascoyne WC Chan, et al. 2004 Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells N Engl J Med 351 2159 2169 1:CAS:528: DC%2BD2cXhtVSqtL%2FP 10.1056/NEJMoa041869 15548776
36. C Ginestier N Cervera P Finetti S Esteyries B Esterni J Adelaide, et al. 2006 Prognosis and gene expression profiling of 20q13-amplified breast cancers Clin Cancer Res 12 4533 4544 1:CAS:528:DC%2BD28XnvVGksr0%3D 10.1158/1078-0432. CCR-05-2339 16899599
37. JE Larsen SJ Pavey LH Passmore R Bowman BE Clarke NK Hayward, et al. 2007 Expression profiling defines a recurrence signature in lung squamous cell carcinoma Carcinogenesis 28 760 766 1:CAS:528:DC%2BD2sXjslOnsLo%3D 10.1093/carcin/bgl207 17082175
38. N Stransky C Vallot F Reyal I Bernard-Pierrot SGD de Medina R Segraves, et al. 2006 Regional copy number-independent deregulation of transcription in cancer Nat Genet 38 1386 1396 1:CAS:528:DC%2BD28Xht1CntrfK 10.1038/ng1923 17099711
39. C Sotiriou P Wirapati S Loi A Harris S Fox J Smeds, et al. 2006 Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 262 272 1:CAS:528:DC%2BD28Xhs1Skt74%3D 10.1093/jnci/djj052 16478745
40. ND Hendrix R Wu R Kuick DR Schwartz ER Fearon KR Cho 2006 Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas Cancer Res 66 1354 1362 1:CAS:528:DC%2BD28XpsVeitQ%3D%3D 10.1158/0008-5472.CAN-05-3694 16452189
41. S Nanni C Priolo A Grasselli M D'Eletto R Merola F Moretti, et al. 2006 Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer Mol Cancer Res 4 79 92 1:CAS:528:DC%2BD28XhvFaitr4%3D 10.1158/1541-7786.MCR-05-0098 16513839
42. NH Segal P Pavlidis WS Noble CR Antonescu A Viale UV Wesley, et al. 2003 Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling J Clin Oncol 21 1775 1781 1:CAS:528:DC%2BD2cXpsVWqtrs%3D 10.1200/JCO.2003.10.108 12721254
43. M Kinoshita 2006 Diversity of septin scaffolds Curr Opin Cell Biol 18 54 60 1:CAS:528:DC%2BD28XmsVGqtA%3D%3D 10.1016/j.ceb.2005.12.005 16356703